Canada markets close in 6 hours 21 minutes

Allarity Therapeutics, Inc. (ALLR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.6700+1.3000 (+94.89%)
As of 09:39AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.67M
Enterprise Value 5.54M
Trailing P/E 0.00
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.35
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.49

Trading Information

Stock Price History

Beta (5Y Monthly) 0.24
52-Week Change 3-99.61%
S&P500 52-Week Change 323.57%
52 Week High 3372.0000
52 Week Low 31.1500
50-Day Moving Average 35.2041
200-Day Moving Average 315.8164

Share Statistics

Avg Vol (3 month) 3556.5k
Avg Vol (10 day) 3491.66k
Shares Outstanding 51.95M
Implied Shares Outstanding 61.95M
Float 8308.66k
% Held by Insiders 10.00%
% Held by Institutions 10.12%
Shares Short (Apr 15, 2024) 4105.06k
Short Ratio (Apr 15, 2024) 40.08
Short % of Float (Apr 15, 2024) 45.40%
Short % of Shares Outstanding (Apr 15, 2024) 45.40%
Shares Short (prior month Mar 15, 2024) 430.71k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Apr 09, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-81.08%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -17.09M
Net Income Avi to Common (ttm)-20.42M
Diluted EPS (ttm)-205.2000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)222k
Total Cash Per Share (mrq)0.72
Total Debt (mrq)1.3M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.14
Book Value Per Share (mrq)-15.26

Cash Flow Statement

Operating Cash Flow (ttm)-12.74M
Levered Free Cash Flow (ttm)-5.47M